These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23908068)

  • 21. Comparison of dosimetry between PET/CT and PET alone using (11)C-ITMM.
    Ito K; Sakata M; Oda K; Wagatsuma K; Toyohara J; Ishibashi K; Ishii K; Ishiwata K
    Australas Phys Eng Sci Med; 2016 Mar; 39(1):177-86. PubMed ID: 26728881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiosynthesis and evaluation of [11C]YM-202074 as a PET ligand for imaging the metabotropic glutamate receptor type 1.
    Yanamoto K; Konno F; Odawara C; Yamasaki T; Kawamura K; Hatori A; Yui J; Wakizaka H; Nengaki N; Takei M; Zhang MR
    Nucl Med Biol; 2010 Jul; 37(5):615-24. PubMed ID: 20610166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and preliminary studies of
    Zhang X; Zhang Y; Chen Z; Shao T; Van R; Kumata K; Deng X; Fu H; Yamasaki T; Rong J; Hu K; Hatori A; Xie L; Yu Q; Ye W; Xu H; Sheffler DJ; Cosford NDP; Shao Y; Tang P; Wang L; Zhang MR; Liang SH
    Theranostics; 2020; 10(24):11178-11196. PubMed ID: 33042277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroprotective activity of selective mGlu1 and mGlu5 antagonists in vitro and in vivo.
    Szydlowska K; Kaminska B; Baude A; Parsons CG; Danysz W
    Eur J Pharmacol; 2007 Jan; 554(1):18-29. PubMed ID: 17109843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of 1-(2-[18F] fluoro-3-pyridyl)-4-(2-isopropyl-1-oxo- isoindoline-5-yl)-5-methyl-1H-1,2,3-triazole, a PET ligand for imaging the metabotropic glutamate receptor type 1 in rat and monkey brains.
    Fujinaga M; Maeda J; Yui J; Hatori A; Yamasaki T; Kawamura K; Kumata K; Yoshida Y; Nagai Y; Higuchi M; Suhara T; Fukumura T; Zhang MR
    J Neurochem; 2012 Apr; 121(1):115-24. PubMed ID: 21668889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Syntheses and pharmacological characterization of novel thiazole derivatives as potential mGluR5 PET ligands.
    Baumann CA; Mu L; Wertli N; Krämer SD; Honer M; Schubiger PA; Ametamey SM
    Bioorg Med Chem; 2010 Aug; 18(16):6044-54. PubMed ID: 20634080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiosynthesis and evaluation of 5-methyl-N-(4-[(11)C]methylpyrimidin-2-yl)-4-(1H-pyrazol-4-yl)thiazol-2-amine ([(11)C]ADX88178) as a novel radioligand for imaging of metabotropic glutamate receptor subtype 4 (mGluR4).
    Fujinaga M; Yamasaki T; Nengaki N; Ogawa M; Kumata K; Shimoda Y; Yui J; Xie L; Zhang Y; Kawamura K; Zhang MR
    Bioorg Med Chem Lett; 2016 Jan; 26(2):370-374. PubMed ID: 26707390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiolabeling and in vitro and in vivo evaluation of [18F]-FE-DABP688 as a PET radioligand for the metabotropic glutamate receptor subtype 5.
    Honer M; Stoffel A; Kessler LJ; Schubiger PA; Ametamey SM
    Nucl Med Biol; 2007 Nov; 34(8):973-80. PubMed ID: 17998101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and evaluation of 4-(2-fluoro-4-[
    Kumata K; Hatori A; Yamasaki T; Zhang Y; Mori W; Fujinaga M; Xie L; Nengaki N; Zhang MR
    Bioorg Med Chem; 2019 Feb; 27(3):483-491. PubMed ID: 30611634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative evaluation of 11C-ABP688 as PET ligand for the measurement of the metabotropic glutamate receptor subtype 5 using autoradiographic studies and a beta-scintillator.
    Wyss MT; Ametamey SM; Treyer V; Bettio A; Blagoev M; Kessler LJ; Burger C; Weber B; Schmidt M; Gasparini F; Buck A
    Neuroimage; 2007 Apr; 35(3):1086-92. PubMed ID: 17320417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced PBR/TSPO expression after minocycline treatment in a rat model of focal cerebral ischemia: a PET study using [(18)F]DPA-714.
    Martín A; Boisgard R; Kassiou M; Dollé F; Tavitian B
    Mol Imaging Biol; 2011 Feb; 13(1):10-5. PubMed ID: 20383592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo evaluation of [18F]-FDEGPECO as a PET tracer for imaging the metabotropic glutamate receptor subtype 5 (mGluR5).
    Wanger-Baumann CA; Mu L; Honer M; Belli S; Alf MF; Schubiger PA; Krämer SD; Ametamey SM
    Neuroimage; 2011 Jun; 56(3):984-91. PubMed ID: 21406237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroprotective effect of Buyang Huanwu decoction against focal cerebral ischemia/reperfusion injury in rats--time window and mechanism.
    Zhao LD; Wang JH; Jin GR; Zhao Y; Zhang HJ
    J Ethnopharmacol; 2012 Mar; 140(2):339-44. PubMed ID: 22306289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-(3,4-Dimethylisoxazol-5-yl)piperazine-4-[4-(2-fluoro-4-[(11)C]methylphenyl)thiazol-2-yl]-1-carboxamide: A promising positron emission tomography ligand for fatty acid amide hydrolase.
    Shimoda Y; Fujinaga M; Hatori A; Yui J; Zhang Y; Nengaki N; Kurihara Y; Yamasaki T; Xie L; Kumata K; Ishii H; Zhang MR
    Bioorg Med Chem; 2016 Feb; 24(4):627-34. PubMed ID: 26740152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noninvasive quantification of metabotropic glutamate receptor type 1 with [¹¹C]ITDM: a small-animal PET study.
    Yamasaki T; Fujinaga M; Yui J; Ikoma Y; Hatori A; Xie L; Wakizaka H; Kumata K; Nengaki N; Kawamura K; Zhang MR
    J Cereb Blood Flow Metab; 2014 Apr; 34(4):606-12. PubMed ID: 24398932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroprotective effects of the selective type 1 metabotropic glutamate receptor antagonist YM-202074 in rat stroke models.
    Kohara A; Takahashi M; Yatsugi S; Tamura S; Shitaka Y; Hayashibe S; Kawabata S; Okada M
    Brain Res; 2008 Jan; 1191():168-79. PubMed ID: 18164695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and preliminary biological evaluation of 3-[(18)F]fluoro-5-(2-pyridinylethynyl)benzonitrile as a PET radiotracer for imaging metabotropic glutamate receptor subtype 5.
    Wang JQ; Tueckmantel W; Zhu A; Pellegrino D; Brownell AL
    Synapse; 2007 Dec; 61(12):951-61. PubMed ID: 17787003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabotropic glutamate 1 (mGlu1) receptor antagonists enhance GABAergic neurotransmission: a mechanism for the attenuation of post-ischemic injury and epileptiform activity?
    Cozzi A; Meli E; Carlà V; Pellicciari R; Moroni F; Pellegrini-Giampietro DE
    Neuropharmacology; 2002 Aug; 43(2):119-30. PubMed ID: 12213266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroprotection by a central nervous system-type prostacyclin receptor ligand demonstrated in monkeys subjected to middle cerebral artery occlusion and reperfusion: a positron emission tomography study.
    Cui Y; Takamatsu H; Kakiuchi T; Ohba H; Kataoka Y; Yokoyama C; Onoe H; Watanabe Y; Hosoya T; Suzuki M; Noyori R; Tsukada H; Watanabe Y
    Stroke; 2006 Nov; 37(11):2830-6. PubMed ID: 17008612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What We Observe In Vivo Is Not Always What We See In Vitro: Development and Validation of 11C-JNJ-42491293, A Novel Radioligand for mGluR2.
    Leurquin-Sterk G; Celen S; Van Laere K; Koole M; Bormans G; Langlois X; Van Hecken A; Te Riele P; Alcázar J; Verbruggen A; de Hoon J; Andrés JI; Schmidt ME
    J Nucl Med; 2017 Jan; 58(1):110-116. PubMed ID: 27469358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.